Fresenius Kabi Ramps Up Production of Essential Drugs Used in Treating Covid-19
April 07 2020 - 4:00AM
Dow Jones News
By Olivia Bugault
Fresenius SE & Co. KGaA said Tuesday that its subsidiary
Fresenius Kabi is scaling up production of critical drugs used in
the treatment of Covid-19.
The health-care company said demand for medicines used for
sedation, such as Propofol or pain-management drugs, has
significantly increased. The medicines will be supplied to Covid-19
patients in priority, it said.
Prices will remain stable for the drugs that are essential
during the treatment of the sickness, the company said.
Write to Olivia Bugault at olivia.bugault@wsj.com
(END) Dow Jones Newswires
April 07, 2020 03:45 ET (07:45 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Fresenius SE and Company... (PK) (USOTC:FSNUY)
Historical Stock Chart
From Jun 2024 to Jul 2024
Fresenius SE and Company... (PK) (USOTC:FSNUY)
Historical Stock Chart
From Jul 2023 to Jul 2024
